{{Rsnum
|rsid=10501570
|Gene=DLG2
|Chromosome=11
|position=84706803
|Orientation=plus
|GMAF=0.09734
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=DLG2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 4.5 | 33.0 | 62.5
| HCB | 0.0 | 3.6 | 96.4
| JPT | 0.0 | 2.7 | 97.3
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 3.5 | 96.5
| CHB | 0.0 | 3.6 | 96.4
| CHD | 0.0 | 4.6 | 95.4
| GIH | 0.0 | 23.8 | 76.2
| LWK | 0.0 | 1.8 | 98.2
| MEX | 3.4 | 34.5 | 62.1
| MKK | 0.0 | 6.4 | 93.6
| TSI | 3.0 | 34.7 | 62.4
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs10501570
|PubMedID=17052657
|Condition=Parkinson's disease
|Gene=DLG2
|Risk Allele=
|pValue=7.00E-006
|OR=5
|95CI=2.00-12.50
}}

{{PharmGKB
|RSID=rs10501570
|Name_s=
|Gene_s=DLG2
|Feature=
|Evidence=PubMed ID:17052657; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data (Initial Sample Size: 267 cases, 270 controls; Replication Sample Size: NR). This variant is associated with Parkinson's disease.
|Drugs=
|Drug Classes=
|Diseases=Parkinson Disease
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356538
}}

{{PMID|19208180|OA=1
}} Detecting disease-associated genotype patterns.

{{PMID|19429005|OA=1
}} Phactr2 and Parkinson's disease.

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10501570
|overall_frequency_n=12
|overall_frequency_d=128
|overall_frequency=0.09375
|n_genomes=12
|n_genomes_annotated=0
|n_haplomes=15
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}